Markets


ACADIA Pharmaceuticals Inc. (ACAD) Hits New 52-Week High Following Breakthrough Therapy Designation; J.P. Morgan Weighs In

ACAD receives BTD in dementia-related psychosis; Initiates DRP phase 3 trial; Phase 2 SERENE trial discontinued.

Why Did Omeros Corporation (OMER) Shares Just Pop?

Drug maker Omeros Corporation (NASDAQ:OMER) announced that it entered into a settlement agreement with Par Pharmaceutical and its subsidiary Par Sterile Products, resolving …

Why You Should Hold Your Horses with Teva Pharmaceutical Industries Ltd (ADR) (TEVA) and Valeant Pharmaceuticals Intl Inc (VRX)

TEVA needs a long-term solution after MYL’s generic Copaxone approval; VRX works on its debt problem.

Amyris Inc (AMRS) to Deliver Human Nutrition Solutions; Enters Agreement with Royal DSM

Amyris, Inc. (NASDAQ:AMRS) announced that it has entered into a product development and production agreement for a new class of human nutrition ingredients …

Celsion Corporation (CLSN) Wins Over Maxim’s Bullish Blessing, Catabasis Pharmaceuticals Inc (CATB) Has Cowen Encouraged After Promising Pivotal DMD Phase II Trial Results

Celsion strikes iron while its hot to raise $15.6 million; Catabasis slows rate of DMD decline in OLE trial.

2 Pharmaceutical Stocks That Can Double in a Year: Global Blood Therapeutics Inc (GBT), TherapeuticsMD Inc (TXMD)

These two pharma stocks all have upside of over 100% say top Wall Street analysts.

Two Smart Money Stocks to Buy for 2018: Micron Technology, Inc. (MU), Alibaba Group Holding Ltd (BABA)

These stocks to buy have significant support from top analysts.

Today’s Short Call on Shopify Inc. (SHOP) Creates a Buying Opportunity: Top Analyst

In a research report issued Wednesday, Baird’s top analyst Colin Sebastian rebuked Citron for its short report on Shopify Inc (US) (NYSE:SHOP), and reiterated his Outperform rating …

Biotech Universe: Mizuho Expects Mylan N.V. (MYL) To Rally, Endocyte, Inc. (ECYT) Brings Wedbush Over To The Bulls

Analysts weigh in with confidence on two biotech stocks blasting through the roof this week.

Shopify Inc (US) (SHOP) Immediate Price Target Implies 50% Downside – Here’s Why

Shopify is a completely illegal get-rich-quick scheme (with a good software platform).

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts